Search

everythinglearnresearchcommunity

for

Search:↓

Safusidenib erbumine shows promise as a treatment for certain brain tumors, but mild side effects like hair loss need attention.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

Recognizing and treating related skin conditions can improve atopic dermatitis management.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Stem cell treatment improved hair density in female hair loss patient.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

Chemotherapy provides symptom relief and extends life in 30-50% of gynecological cancer cases, but has only cured choriocarcinoma.

Adipose tissue-derived therapies show promise for improving osteoarthritis symptoms but need more research for safety and effectiveness.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

The doxazosin plus tamsulosin combination improved symptoms effectively with fewer side effects.

Mesenchymal stem cells from laser-assisted liposuction are as effective and safe as those from conventional methods for cell therapy.

Early baldness increases prostate cancer risk, radiotherapy and surgery have similar second cancer rates, and ALA may reduce prostate cancer risk.

A woman's adrenal tumor disappeared after treatment with cyproterone acetate.

Dutasteride improved both hair loss and acne in two young men.

Dutasteride effectively and safely treats male hair loss for over a year.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

The treatment was effective for advanced non-Hodgkin's lymphomas.

5-alpha-reductase inhibitors lower PSA density but higher PSA density indicates disease progression.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Topical finasteride with EGCG or TA improves drug release and dermal uptake, potentially treating hair loss effectively.

Dutasteride works better than finasteride for hair loss and has mild, reversible side effects.